ipilimumab,nivolumab
bms
['kidney cancer', 'ipi/', 'nivo']
pretty amazing how good the response rates are to pd-1/ctla-4 bispecifics in cervical cancer and kidney cancer - better than ipi/nivo! #asco2022
PhD microbiology | medical writer | immunotherapy | ??????? | ?? | ??????? | ?????? | he/him/his | affiliated w/ @dadaohou | mostly irreverent